Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001398344-24-020926
Filing Date
2024-11-14
Accepted
2024-11-14 17:21:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5109
  Complete submission text file 0001398344-24-020926.txt   6788
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Subject) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91451 | Film No.: 241464405
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address AM BELVEDERE 1 VIENNA C4 1100
Business Address AM BELVEDERE 1 VIENNA C4 1100 00435010017188
Erste Asset Management GmbH (Filed by) CIK: 0002024532 (see all company filings)

EIN.: 000000000 | State of Incorp.: C4
Type: SCHEDULE 13G/A